Nicotinic receptors modulating somatodendritic and terminal dopamine release differ pharmacologically

European Journal of Pharmacology

Volumn 393, Issue 1-3, 2000, Pages 39-49

  Reuben, Melanie ^a   Boye, Sandra ^a   Clarke, Paul B S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Dendrosome; Epibatidine; Nicotinic receptor; Somatodendritic; Substantia nigra; Ventral tegmental area

Indexed keywords

ACETYLCHOLINE; AMPHETAMINE; CHOLINERGIC RECEPTOR; CYTISINE; EPIBATIDINE; MECAMYLAMINE; MESSENGER RNA; METIROSINE; NICOTINE; NICOTINIC RECEPTOR; NOMIFENSINE; POTASSIUM ION; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; TETRODOTOXIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BRAIN SYNAPTOSOME; CONFERENCE PAPER; CONTROLLED STUDY; CORPUS STRIATUM; DENDRITIC CELL; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; ELECTROPHYSIOLOGY; HIPPOCAMPUS; IN VITRO STUDY; LOCOMOTION; MALE; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; CORPUS STRIATUM; DOPAMINE; HIPPOCAMPUS; MALE; MECAMYLAMINE; MOTOR ACTIVITY; NEURONS; NICOTINE; NICOTINIC AGONISTS; NICOTINIC ANTAGONISTS; NOREPINEPHRINE; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; RECOMBINANT PROTEINS; SYNAPTOSOMES; TETRODOTOXIN; TRITIUM;

EID: 0034732365     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(00)00004-2     Document Type: Conference Paper

References (58)

1. Alkondon M., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons: III. Agonist actions of the novel alkaloid epibatidine and analysis of type II current. J. Pharmacol. Exp. Ther. 274:1995;771-782.
2. Aston-Jones G., Shipley M.T., Grzanna R. The locus coeruleus, A5 and A7 noradrenergic cell groups. Paxinos G. The Rat Nervous System. 2nd edn. 1995;183-213 Academic Press, New York.
3. Benwell M.E.M., Balfour D.J.K., Lucchi H.M. Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology. 112:1993;467-474.
4. Charpantier E., Barnéoud P., Moser P., Besnard F., Sgard F. Nicotinic acetylcholine subunit mRNA expression in dopaminergic neurons of the rat substantia nigra and ventral tegmental area. NeuroReport. 9:1998;3097-3101.
5. Clarke P.B.S., Kumar R. Characterization of the locomotor stimulant action of nicotine in tolerant rats. Br. J. Pharmacol. 80:1983;587-594.
6. Clarke P.B.S., Pert A. Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res. 348:1985;355-358.
7. 3H]-dopamine release. Br. J. Pharmacol. 117:1996;595-606.
8. Colquhoun L.M., Patrick J.W. α3, β2, and β4 form heterotrimeric neuronal nicotinic acetylcholine receptors in Xenopus oocytes. J. Neurochem. 69:1997;2355-2362.
9. Corrigall W.A., Coen K.M., Adamson K.L. Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res. 653:1994;278-284.
10. Damaj M.I., Creasy K.R., Grove A.D., Rosecrans J.A., Martin B.R. Pharmacological effects of epibatidine optical enantiomers. Brain Res. 664:1994;34-40.
11. Dineley-Miller K., Patrick J. Gene transcripts for the nicotinic acetylcholine receptor subunit, beta4, are distributed in multiple areas of the rat central nervous system. Brain Res. Mol. Brain Res. 16:1992;339-344.
12. Egan T.M., North R.A. Actions of acetylcholine and nicotine on rat locus coeruleus neurons in vitro. Neuroscience. 19:1986;565-571.
13. El-Bizri H., Clarke P.B.S. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine and other nicotinic antagonists administered in vitro. Br. J. Pharmacol. 111:1994;406-413.
14. 6 subunit forms functional heteromeric acetylcholine receptors in human transfected cells. Eur. J. Neurosci. 10:1998;172-178.
15. 3H]norepinephrine from fetal rat locus coeruleus cells in culture. J. Neurochem. 70:1998;663-670.
16. Gerzanich V., Kuryatov A., Anand R., Lindstrom J. "Orphan" α6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. Mol. Pharmacol. 51:1997;320-327.
17. Glantz S.A. Primer of Biostatistics. 3rd edn. 1992;McGraw-Hill, New York.
18. Göldner F.M., Dineley K.T., Patrick J.W. Immunohistochemical localization of the nicotinic acetylcholine receptor subunit α6 to dopaminergic neurons in the substantia nigra and ventral tegmental area. NeuroReport. 8:1997;2739-2742.
19. 3H]dopamine release from synaptosomes prepared from mouse striatum. J. Neurochem. 59:1992;848-856.
20. Hefti F., Lichtensteiger W. Subcellular distribution of dopamine in substantia nigra of the rat brain: effects of gamma-butyrolactone and destruction of noradrenergic afferents suggest formation of particles from dendrites. J. Neurochem. 30:1978;1217-1230.
21. Hyttel J. Pharmacological characterization of selective serotonin reuptake inhibitors (SSRIs). Int. Clin. Psychopharmacol. 9(Suppl. 1):1994;19-26.
22. 3H]dopamine release from rat striatal synaptosomes and slices. J. Neurochem. 70:1998;1069-1076.
23. Kalivas P.W., Duffy P. A comparison of axonal and somatodendritic dopamine release using in vivo dialysis. J. Neurochem. 56:1991;961-967.
24. 3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro. J. Neurochem. 45:1985;137-144.
25. Kulak J.M., Nguyen T.A., Olivera B.M., McIntosh J.M. Alpha-conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J. Neurosci. 17:1997;5263-5270.
26. Lauffer L., Hucho F. Triphenylmethylphosphonium is an ion channel ligand of the nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. USA. 79:1982;2406-2409.
27. Le Novère N., Zoli M., Changeux J.P. Neuronal nicotinic receptor α6 subunit mRNA is selectively concentrated in catecholaminergic nuclei of the rat brain. Eur. J. Neurosci. 8:1996;2428-2439.
28. Le Novère N., Zoli M., Léna C., Ferrari R., Picciotto M.R., Merlo Pich E., Changeux J.-P. Involvement of alpha6 nicotinic receptor subunit in nicotine-elicited locomotion, demonstrated by in vivo antisense oligonucleotide infusion. NeuroReport. 10(12):1999;. in press.
29. Léna C., Changeux J.-P., Mulle C. Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13:1993;2680-2688.
30. Louis M., Clarke P.B.S. Effect of ventral tegmental 6-hydroxydopamine lesions on the locomotor stimulant action of nicotine in rats. Neuropharmacology. 37:1998;1503-1513.
31. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:1998;648-657.
32. Luetje C.W., Patrick J. Both alpha- and beta-subunits contribute to the agonist sensitivity of neuronal nicotinic acetylcholine receptors. J. Neurosci. 11:1991;837-845.
33. Luo S.Q., Kulak J.M., Cartier G.E., Jacobsen R.B., Yoshikami D., Olivera B.M., McIntosh J.M. α-Conotoxin AuIB selectively blocks α3β4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18:1998;8571-8579.
34. 3H]dopamine release from dendrosomes of rat substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 344:1991;275-280.
35. + efflux from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 274:1995;833-841.
36. + efflux from mouse thalamic synaptosomes. J. Pharmacol. Exp. Ther. 277:1996;1383-1396.
37. Marshall D., Soliakov L., Redfern P., Wonnacott S. Tetrodotoxin-sensitivity of nicotine-evoked dopamine release from rat striatum. Neuropharmacology. 35:1996;1531-1536.
38. Menzaghi F., Whelan K.T., Risbrough V.B., Rao T.S., Lloyd G.K. Effects of a novel cholinergic ion channel agonist SIB-1765F on locomotor activity in rats. J. Pharmacol. Exp. Ther. 280:1997;384-392.
39. Nirenberg M.J., Chan J., Liu Y.J., Edwards R.H., Pickel V.M. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: potential sites for somatodendritic storage and release of dopamine. J. Neurosci. 16:1996;4135-4145.
40. Nisell M., Nomikos G.G., Svensson T.H. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area. Synapse. 16:1994;36-44.
41. Papke R.L., Heinemann S.F. Partial agonist properties of cytisine on neuronal nicotinic receptors containing the β2 subunit. Mol. Pharmacol. 45:1994;142-149.
42. Picciotto M.R., Zoli M., Rimondini R., Léna C., Marubio L.M., Pich E.M., Fuxe K., Changeux J.P. Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine. Nature. 391:1998;173-177.
43. Pidoplichko V.I., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 390:1997;401-404.
44. Pittaluga A., Raiteri M. N-methyl-D-aspartic acid (NMDA) and non-NMDA receptors regulating hippocampal norepinephrine release: I. Location on axon terminals and pharmacological characterization. J. Pharmacol. Exp. Ther. 260:1992;232-237.
45. Rapier C., Lunt G.G., Wonnacott S. Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J. Neurochem. 50:1988;1123-1130.
46. 3H]5-hydroxytryptamine release from rat striatal synaptosomes. Neuropharmacology. 1999;. in press.
47. Sabey K., Paradiso K., Zhang J., Steinbach J.H. Ligand binding and activation of rat nicotinic α4β2 receptors stably expressed in HEK293 cells. Mol. Pharmacol. 55:1999;58-66.
48. Sacaan A.I., Dunlop J.L., Lloyd G.K. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274:1995;224-230.
49. Schilström B., Nomikos G.G., Nisell M., Hertel P., Svensson T.H. N-methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience. 82:1998a;781-789.
50. Schilström B., Svensson H.M., Svensson T.H., Nomikos G.G. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of α7 nicotinic receptors in the ventral tegmental area. Neuroscience. 85:1998b;1005-1009.
51. 7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:1993;596-604.
52. Sorenson E.M., Shiroyama T., Kitai S.T. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience. 87:1998;659-673.
53. Sullivan J.P., Decker M.W., Brioni J.D., Donnelly-Roberts D., Anderson D.J., Bannon A.W., Kang C.-H., Adams P., Piattoni-Kaplan M., Buckley M.J.et al. (±)-epibatidine elicits a diversity of in vitro and in vivo effects mediated by nicotinic acetylcholine receptors. J. Pharmacol. Exp. Ther. 271:1994;624-631.
54. Whiting P., Lindstrom J. Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. USA. 84:1987;595-599.
55. Wilkie G.I., Hutson P.H., Stephens M.W., Whiting P., Wonnacott S. Hippocampal nicotinic autoreceptors modulate acetylcholine release. Biochem. Soc. Trans. 21:1993;429-431.
56. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci. 20:1997;92-98.
57. Zoli M., Léna C., Picciotto M.R., Changeux J.P. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J. Neurosci. 18:1998;4461-4472.
58. Zwart R., Abraham D., Oortgiesen M., Vijverberg H.P.M. α4β2 subunit combination specific pharmacology of neuronal nicotinic acetylcholine receptors in N1E-115 neuroblastoma cells. Brain Res. 654:1994;312-318.